ATE148632T1 - Synergistische therapeutische zusammensetzungen und verfahren - Google Patents

Synergistische therapeutische zusammensetzungen und verfahren

Info

Publication number
ATE148632T1
ATE148632T1 AT91909382T AT91909382T ATE148632T1 AT E148632 T1 ATE148632 T1 AT E148632T1 AT 91909382 T AT91909382 T AT 91909382T AT 91909382 T AT91909382 T AT 91909382T AT E148632 T1 ATE148632 T1 AT E148632T1
Authority
AT
Austria
Prior art keywords
methods
therapeutic compositions
synergistic therapeutic
synergistic
compositions
Prior art date
Application number
AT91909382T
Other languages
English (en)
Inventor
Anthony Andrea Fossa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24080550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE148632(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE148632T1 publication Critical patent/ATE148632T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91909382T 1990-05-11 1991-04-22 Synergistische therapeutische zusammensetzungen und verfahren ATE148632T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52236090A 1990-05-11 1990-05-11

Publications (1)

Publication Number Publication Date
ATE148632T1 true ATE148632T1 (de) 1997-02-15

Family

ID=24080550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909382T ATE148632T1 (de) 1990-05-11 1991-04-22 Synergistische therapeutische zusammensetzungen und verfahren

Country Status (33)

Country Link
US (2) US6900234B1 (de)
EP (1) EP0527879B1 (de)
JP (2) JPH0729938B2 (de)
KR (1) KR970005839B1 (de)
CN (7) CN1915428A (de)
AP (1) AP240A (de)
AT (1) ATE148632T1 (de)
AU (1) AU653724B2 (de)
BG (1) BG61831B1 (de)
BR (1) BR9106438A (de)
CA (1) CA2081564C (de)
DE (1) DE69124598T2 (de)
DK (1) DK0527879T3 (de)
EG (1) EG19648A (de)
ES (1) ES2097208T3 (de)
GR (1) GR3022997T3 (de)
GT (1) GT199100032A (de)
HU (1) HU227346B1 (de)
IE (1) IE911592A1 (de)
IL (1) IL98055A (de)
IS (1) IS2042B (de)
MA (1) MA22150A1 (de)
MY (1) MY114347A (de)
NO (1) NO924321L (de)
NZ (1) NZ238118A (de)
PE (1) PE30891A1 (de)
PT (1) PT97615B (de)
RO (1) RO115786B1 (de)
RU (1) RU2147875C1 (de)
TW (1) TW203553B (de)
WO (1) WO1991017771A1 (de)
YU (1) YU49094B (de)
ZA (1) ZA913539B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2147875C1 (ru) * 1990-05-11 2000-04-27 Пфайзер Инк. Способ и композиция для снижения кровяного давления и лечения застойной сердечной недостаточности у млекопитающего
EP0629408A1 (de) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Kombination von Angiotensin-Converting-Enzyme Hemmern mit A-II-Antagonisten
DE4340437C1 (de) * 1993-11-27 1995-05-24 Karla Dr Lehmann Verwendung von Lithiumverbindungen zur Behandlung von Herzinsuffizienz einschließlich ihrer Folgeerkrankungen
WO1996031234A1 (en) * 1995-04-07 1996-10-10 Novartis Ag Combination compositions containing benazepril or benazeprilat and valsartan
CA2224451A1 (en) * 1995-06-30 1997-01-23 Merck & Co., Inc. Method of treating renal disease using an ace inhibitor and an aii antagonist
US6107323A (en) 1996-04-05 2000-08-22 Takeda Chemical Industries, Ltd. Pharmaceutical composition
ATE216881T1 (de) * 1996-06-24 2002-05-15 Merck & Co Inc Zusammensetzung auf basis von enalapril und losartan
US6087386A (en) * 1996-06-24 2000-07-11 Merck & Co., Inc. Composition of enalapril and losartan
AU9509798A (en) * 1997-09-25 1999-04-12 University Of Florida Antisense oligonucleotide compositions targeted to angiotensi n converting enzy me mrna and methods of use
KR20010033473A (ko) * 1997-12-23 2001-04-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Ａｃｅ 저해제-ｍｍｐ 저해제의 병용 제제
US6087343A (en) * 1998-09-14 2000-07-11 University Of Florida Antisense oligonucleotides targeted to β-1 adrenoceptor and methods of use
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
WO2004002549A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
HRP20150037T4 (hr) 2003-04-08 2022-09-02 Progenics Pharmaceuticals, Inc. Farmaceutske formulacije koje sadrže metilnaltrekson
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
EP2248520A3 (de) * 2004-10-08 2010-11-17 Novartis AG Verwendung von Reninhemmern zur Prävention oder Behandlung von diastolischer Dysfunktion oder diastolischer Herzinsuffizienz
CN101171010B (zh) * 2005-03-07 2014-09-17 芝加哥大学 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
CA2682129A1 (en) 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Crystal forms and uses thereof
US8546418B2 (en) 2007-03-29 2013-10-01 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
PT2139890E (pt) 2007-03-29 2014-09-03 Wyeth Llc Antagonistas do receptor opióide periférico e respectivas utilizações
EP2240489A1 (de) 2008-02-06 2010-10-20 Progenics Pharmaceuticals, Inc. HERSTELLUNG UND VERWENDUNG VON (R), (R)-2,2ýBIS-METHYLNALTREXON
EP2278966B1 (de) 2008-03-21 2019-10-09 The University of Chicago Behandlung mit opioid-antagonisten und mtor-inhibitoren
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
AR077692A1 (es) 2009-08-06 2011-09-14 Vitae Pharmaceuticals Inc Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
CN102423483A (zh) * 2011-11-24 2012-04-25 西北农林科技大学 一种复方雷米普利纳米乳抗高血压药物
CN114032273B (zh) * 2021-11-17 2024-02-02 山东省科学院生物研究所 一种多功能西洋参水解肽及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US324377A (en) * 1885-08-18 Roller-skate
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
US4749688A (en) 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3633861A1 (de) * 1986-10-04 1988-04-07 Thomae Gmbh Dr K Neue imidazo-benzoxazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4814342A (en) 1986-10-31 1989-03-21 Pfizer Inc. Nor-statine and nor-cyclostatine polypeptides
US4895834A (en) * 1986-12-15 1990-01-23 Warner-Lambert Company Renin inhibitors III
WO1988005432A1 (fr) * 1987-01-23 1988-07-28 Yoshitomi Pharmaceutical Industries, Ltd. Compose de 5-hydroxyindole-3-carboxamide et son usage en medecine
US4962105A (en) 1987-10-19 1990-10-09 Ciba-Geigy Corporation Potentiation of antihypertensive effect of ace inhibitors
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
CA1338238C (en) 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
IL91780A (en) 1988-10-04 1995-08-31 Abbott Lab History of the amine of the xenon-preventing xanine acid, the process for their preparation and the pharmaceutical preparations containing them
RU2147875C1 (ru) * 1990-05-11 2000-04-27 Пфайзер Инк. Способ и композиция для снижения кровяного давления и лечения застойной сердечной недостаточности у млекопитающего

Also Published As

Publication number Publication date
TW203553B (de) 1993-04-11
EP0527879A1 (de) 1993-02-24
YU49094B (sh) 2003-12-31
MA22150A1 (fr) 1991-12-31
HU227346B1 (en) 2011-04-28
GT199100032A (es) 1992-10-31
IS2042B (is) 2005-09-15
HUT62804A (en) 1993-06-28
CN1879884A (zh) 2006-12-20
EG19648A (en) 1995-09-30
ES2097208T3 (es) 1997-04-01
DE69124598D1 (de) 1997-03-20
CN1915428A (zh) 2007-02-21
CN1502370A (zh) 2004-06-09
CN1065140C (zh) 2001-05-02
PT97615A (pt) 1992-03-31
IL98055A (en) 1996-10-31
AU7859191A (en) 1991-12-10
IS3703A7 (is) 1991-11-12
JP2635291B2 (ja) 1997-07-30
GR3022997T3 (en) 1997-07-30
US6900234B1 (en) 2005-05-31
CA2081564A1 (en) 1991-11-12
YU81991A (sh) 1994-06-24
ZA913539B (en) 1992-12-30
BG97068A (bg) 1993-12-24
JPH0729938B2 (ja) 1995-04-05
JPH05505618A (ja) 1993-08-19
NO924321D0 (no) 1992-11-10
DE69124598T2 (de) 1997-05-28
AU653724B2 (en) 1994-10-13
PT97615B (pt) 1998-08-31
JPH0748280A (ja) 1995-02-21
CN1824315B (zh) 2011-01-12
CN100358578C (zh) 2008-01-02
NZ238118A (en) 1997-06-24
MY114347A (en) 2002-10-31
PE30891A1 (es) 1991-11-27
RO115786B1 (ro) 2000-06-30
CN1056426A (zh) 1991-11-27
NO924321L (no) 1993-01-08
BG61831B1 (bg) 1998-07-31
AP240A (en) 1993-02-18
RU2147875C1 (ru) 2000-04-27
WO1991017771A1 (en) 1991-11-28
US6716875B1 (en) 2004-04-06
CN101156949A (zh) 2008-04-09
IL98055A0 (en) 1992-06-21
AP9100258A0 (en) 1991-07-31
HK1094148A1 (en) 2007-03-23
BR9106438A (pt) 1993-05-18
KR970005839B1 (ko) 1997-04-21
EP0527879B1 (de) 1997-02-05
IE911592A1 (en) 1991-11-20
DK0527879T3 (da) 1997-07-14
CN1307901A (zh) 2001-08-15
HU9203522D0 (en) 1993-01-28
CA2081564C (en) 1998-02-03
CN1824315A (zh) 2006-08-30

Similar Documents

Publication Publication Date Title
DE69124598D1 (de) Synergistische therapeutische zusammensetzungen und verfahren
NO941929L (no) Tokotrienoler og tokotrienol-lignende sammensetninger og fremgangsmåter for deres anvendelse
FI931085A7 (fi) Kasvainten vastaisia koostumuksia ja hoitomenetelmiä
FI940932A7 (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
DE69230954D1 (de) Modulare Schnittstelle und Verfahren hierfür
FI951197A7 (fi) Mikrobisidiset koostumukset ja menetelmät
DE69324942D1 (de) Strahlungsempfindliche Zusammensetzungen und Verfahren
FI953593L (fi) G-CSF-analogikoostumuksia ja menetelmiä
DE69211276D1 (de) Verfahren und Schleifvorrichtung
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DE68928033D1 (de) Stereosynthesizer und entsprechendes verfahren
BR1100824A (pt) Composto e composição farmacêutica
MX174001B (es) Composiciones cementicias y metodo
NO933601D0 (no) Forbedret ligningsbasert treklebemiddel
DE69212502D1 (de) Klebstoffzusammensetzung und verfahren
SG42865A1 (en) Therapeutic compositions and methods
FI934926A7 (fi) Adsorbenttikoostumuksia ja menetelmiä niiden valmistamiseksi
NO912773D0 (no) Antitumor-sammensetninger og fremgangsmaater for behandling
ITTO910114A0 (it) Composizioni e procedimenti di placcatura
DE69312499D1 (de) Kautschukzusammensetzungen enthaltend epoxidierten naturkautschuk und naturkautschuk
FI964936L (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
DE69024818D1 (de) Zusammensetzungen und verfahren zur gewichtsverringerung
ITMI931125A0 (it) Composizioni dentarie e di ricostruzione
FI911644A7 (fi) Terapeuttinen yhdiste ja koostumus
DE69115602D1 (de) Haarbehandlungszusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time